Stifel Comments on Phathom Pharmaceuticals Inc. (NASDAQ: PHAT)The analyst comments "Citizen’s Petition puts FDA on a timeline: PHAT has taken ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE